MB
Michael Binkley
Research areas: Medicine · Pathology and Forensic Medicine · Lymphoma Diagnosis and Treatment · Advanced Radiotherapy Techniques · Lung Cancer Diagnosis and Treatment
0000-0002-2640-5255
Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (88)
- Rosai-Dorfman Disease: A 30-Year Institutional Study of Clinical Features, Treatment Patterns, and Outcomes Save
- Risk Factors of Cardiotoxicity After Breast Cancer Radiation Therapy Save
- Distinct cell state ecosystems for nodular lymphocyte-predominant Hodgkin lymphoma. Save
- Data from Integrating ctDNA Analysis and Radiomics for Dynamic Risk Assessment in Localized Lung Cancer Save
- Figures S1-S8 from Integrating ctDNA Analysis and Radiomics for Dynamic Risk Assessment in Localized Lung Cancer Save
- Integrating ctDNA Analysis and Radiomics for Dynamic Risk Assessment in Localized Lung Cancer Save
- Table S1-S10 from Integrating ctDNA Analysis and Radiomics for Dynamic Risk Assessment in Localized Lung Cancer Save
- Patient and care partner perspectives on treatment decision-making in nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL): a Global nLPHL One Working Group (GLOW) study Save
- Global nLPHL One Working Group (GLOW) Research Roadmap for Nodular Lymphocyte‐Predominant Hodgkin Lymphoma Save
- An ultrasensitive method for detection of cell-free RNA Save
- Urgent and emergent radiotherapy for hematologic malignancies of the central nervous system: a review of the literature and practical approach. Save
- An International Lymphoma Radiation Oncology Group Study of Radiation Therapy for Bilateral Indolent Orbital Adnexal Lymphomas. Save
- Mapping the Tumor Microenvironment of Pediatric Classic Hodgkin Lymphoma Unveils a Unique Spatial Composition and Prognostic Microenvironment Populations Save
- Evolutionary Pressures Shape Undifferentiated Pleomorphic Sarcoma Development and Radiotherapy Response. Save
- Rising to the Top: How Immune-Checkpoint Inhibitors are Changing the Landscape of Treatment for Classic Hodgkin Lymphoma. Save
- Impact of Myc-Altered Pathology on Radiotherapy Efficacy Among Patients with Relapsed/Refractory Large-B Cell Lymphoma: A Collaborative Study by XXX: Impact of double hit pathology on RT efficacy. Save
- A Standard Operating Protocol for Pre-Transplant Low Dose Splenic Radiotherapy for Patients with Myelofibrosis Save
- Comprehensive Characterization of the Cell States and Ecosystems in Classic Hodgkin Lymphoma Using Single-Cell RNA-Seq, Digital Deconvolution, and Machine Learning Save
- Distinct Molecular Aberrations of Classic Hodgkin Lymphoma in Older Adults Identified By Comprehensive Genomic Profiling Save
- Investigating Treatment Kinetics and Local Response during and after Bridging Radiotherapy Prior to CAR-T Cell Therapy for Lymphomas Save